BRCA1/2 test results for all tested patients and by period of diagnosis (period I and period II)
| All tested patients | Tested patients diagnosed in period I* | Tested patients diagnosed in period II* | P value | ||||
| n=201 | n=137 | n=64 | |||||
| N | % | N | % | N | % | ||
| No GPV | 186 | 92.5 | 126 | 92.0 | 60 | 93.8 | |
| BRCA1/2 GPVs detected | 15 | 7.5 | 11 | 8.0 | 4 | 6.3 | 0.269 |
| BRCA1 GPV | 10 | 5.0 | 6 | 4.4 | 4 | 6.3 | |
| BRCA2 GPV | 5 | 2.5 | 5 | 3.6 | – | – | |
| Somatic BRCA1/2 PVs detected | 9 | 4.5 | 4† | 2.9 | 5 | 7.8 | |
| Somatic BRCA1 PV | 6 | 3.0 | 4 | 2.9 | 2 | 3.1 | |
| Somatic BRCA2 PV | 3 | 1.5 | – | – | 3 | 4.7 | |
*Period I: January 1, 2016, until July 1, 2018. Period II: July 1, 2018, until January 1, 2020.
†Tumor tests were performed after July 1, 2018.
GPV, germline pathogenic variant; PV, pathogenic variant.